Intra-Cellular Therapies Inc (NASDAQ:ITCI)

24.15
Delayed Data
As of 11:55am ET
 -0.58 / -2.35%
Today’s Change
12.67
Today|||52-Week Range
30.72
+36.83%
Year-to-Date
No recent news for Intra-Cellular Therapies Inc.

Today’s Trading

Previous close24.73
Today’s open24.60
Day’s range23.99 - 24.69
Volume58,278
Average volume (3 months)173,027
Market cap$863.8M
Dividend yield--
Data as of 11:55am ET, 03/31/2015

Growth & Valuation

Earnings growth (last year)+31.41%
Earnings growth (this year)-152.34%
Earnings growth (next 5 years)--
Revenue growth (last year)-78.91%
P/E ratioNM
Price/Sales875.93
Price/Book6.05

Competitors

 Today’s
change
Today’s
% change
RGLSRegulus Therapeutics...-0.12-0.67%
OMEROmeros Corp-0.98-4.38%
RPTPRaptor Pharmaceutica...-1.15-9.55%
TKMRTekmira Pharmaceutic...-0.29-1.64%
Data as of 12:09pm ET, 03/31/2015

Financials

Next reporting dateMay 4, 2015
EPS forecast (this quarter)-$0.63
Annual revenue (last year)$577.3K
Annual profit (last year)-$30.7M
Net profit margin-5,316.37%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman, President &
Chief Executive Officer
Sharon Mates
Chief Financial Officer, Secretary &
VP
Lawrence J. Hineline
Corporate headquarters
New York, New York

Forecasts

To view my watchlist

Not a member yet?

Sign up now for a free account